Vivos Inc (RDGL)

[MikeD]

Growth in the overall brachytherapy industry- "The global brachytherapy market size was valued at USD 788.5 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.1% from 2021 to 2028."

https://www.grandviewresearch.com/industry-analysis/brachytherapy-devices-market

Dr Korenko: "We have the highest therapeutic ratio of any other brachytherapy device."

Dr. Korenko on Vivos Finances: "Achieved a clean balance sheet and capital structure with our financials with no toxic debt or derivatives."

https://irdirect.net/prviewer/release_only/id/4606767

Imo Dr. Korenko has taken the conservative step by step approach with the FDA and by taking each step it shows product efficacy and returns more data. I hope that enough of the Mayo Clinic and Dr Korenko nonclinical and clinical data can now be produced allowing Dr. Korenko to take a leap and go for a FDA Authorized Pivotal Study next with a bigger pool size. In all likelihood he may stick with the current academic approach and go with the Traditional Feasibility Study next. Either way that is company GROWTH! $RDGL